Vyleesi reviews from real users cover how the PT-141 injection feels, how long effects last, side effects, and cost. Here is what the evidence shows.
Vyleesi reviews generally describe a self-injected prescription drug called bremelanotide (also known as PT-141) that can increase sexual desire in premenopausal women with hypoactive sexual desire disorder (HSDD). Most people who respond feel something within 30 to 60 minutes, notice a window of a few hours, and deal with nausea or flushing that often eases with repeat doses. Vyleesi does not work for everyone, and it is FDA-approved only for premenopausal women.
What Vyleesi Is and Who It Is Approved For
Vyleesi is the brand name for bremelanotide, a melanocortin receptor agonist that is injected under the skin. The FDA approved it in 2019 for acquired, generalized HSDD in premenopausal women, a condition defined by persistently low sexual desire that causes personal distress.
- Dose: 1.75 mg injected into the abdomen or thigh.
- Timing: at least 45 minutes before anticipated sexual activity.
- Limits: no more than one dose in 24 hours and no more than eight doses per month.
- Not approved for: men, postmenopausal women, or anyone under 18.
Bremelanotide is a derivative of a peptide originally studied for skin tanning, and it was later tested for erectile dysfunction before researchers turned to female sexual desire. Vyleesi is not a hormone and not a lubricant; it acts on signaling pathways in the brain.
How Does Vyleesi Make You Feel? What Reviews Actually Report
When people ask how does vyleesi make you feel, the honest answer from most reviews is subtle rather than dramatic. Users describe a gradual return of interest and responsiveness in the hours after the shot, not instant arousal.
- Onset: 30 to 60 minutes after injection for most responders.
- Duration: roughly two to four hours, which is shorter than many first-time users expect.
- Character: increased interest and easier arousal, rather than a distinct physical sensation.
- Non-responders: a noticeable share of users report no change at all.
Clinical trials support that mixed picture. In the RECONNECT studies, women taking bremelanotide showed small but statistically significant improvements in desire and distress scores compared with placebo. Small is the key word, which is why online accounts range from enthusiastic to disappointed.
Vyleesi Side Effects and Safety
Reading through vyleesi side effects accounts, nausea and flushing come up again and again. Most reactions are mild and temporary, but a few require medical attention.
| Side effect | Roughly how often | What users report |
|---|---|---|
| Nausea | About 40% | Most common complaint; often eases after the first few doses |
| Flushing | About 20% | Warmth in the face and neck that fades within an hour or two |
| Headache | About 11% | Usually mild and short-lived |
| Injection site reactions | About 13% | Bruising, itching, or soreness at the abdomen or thigh |
| Darkening of the skin | Uncommon | Focal hyperpigmentation that can persist after stopping |
| Blood pressure changes | Uncommon | Small temporary rise; avoid with uncontrolled hypertension |
Vyleesi is contraindicated for people with uncontrolled high blood pressure or known cardiovascular disease, and for anyone taking oral naltrexone. Vyleesi is not FDA-approved for men, and no nasal spray version has been reviewed or approved by the FDA for any use. Anyone with heart risk factors should clear bremelanotide with a healthcare professional before the first dose.
Vyleesi Cost and Insurance Coverage
The vyleesi cost picture is one of the loudest complaints in reviews. Without insurance, the drug has been priced in the hundreds of dollars per package, and many plans require prior authorization or proof that other options failed first.
Ways people lower the price:
- Manufacturer savings cards, which can reduce the copay for commercially insured patients.
- Telehealth programs that ship the drug directly, sometimes at a flat monthly rate.
- Checking whether the prescription falls under the pharmacy benefit or the medical benefit.
Cash-pay telehealth sellers are common, and not all of them are transparent about sourcing. Ask whether the product is the FDA-approved pen or a compounded version.
Vyleesi vs Addyi: How the Two Compare
Most vyleesi vs addyi discussions come down to one question: do you prefer an injection taken as needed, or a pill taken every night? Both are approved for premenopausal women with acquired, generalized HSDD.
| Feature | Vyleesi (bremelanotide) | Addyi (flibanserin) |
|---|---|---|
| Form | Subcutaneous injection | Oral tablet |
| Dosing | As needed, 45 minutes before activity | Once daily at bedtime |
| Common side effects | Nausea, flushing, headache | Dizziness, sleepiness, nausea, fatigue |
| Alcohol | No specific label restriction; ask your prescriber | Label advises against drinking |
| Key interaction | Contraindicated with oral naltrexone | Many CYP3A4 interactions |
| Monthly rhythm | Up to eight doses per month | Daily and continuous |
Reviews tend to split by lifestyle more than by effectiveness. People who dislike a nightly pill often prefer the on-demand shot, while people who dislike needles usually prefer Addyi.
PT-141 for Men and Nasal Spray Products
Bremelanotide is widely discussed under its research name, PT-141, and PT-141 experience reports from men are easy to find on forums. Vyleesi is not FDA-approved for men, and men who use bremelanotide generally do so off-label or with compounded products of uncertain quality.
Nasal sprays sold as PT-141 are the murkiest category of all. No nasal bremelanotide product has been approved by the FDA, so potency, sterility, and dosing accuracy are unverified. Posts in pt-141 nasal spray reddit threads often mix compounded spray experiences with the approved injectable, which makes those reports nearly impossible to compare.
People researching performance or body-composition compounds often read across categories, from somatropin reviews to peptides marketed for fat loss. None of those products treat HSDD, and combining them with bremelanotide adds risk without a clear benefit.
Questions to Ask a Prescriber Before You Start
- Do my symptoms actually match acquired, generalized HSDD, or could another condition explain them?
- Do I have blood pressure or heart issues that make bremelanotide unsafe for me?
- What is my out-of-pocket cost after insurance, and are there savings programs available?
- What should I do if nausea is unpleasant or the dose does nothing after several tries?
Vyleesi is a prescription treatment, not a supplement, and it is not a fix for relationship strain, medication side effects, or hormonal changes a clinician has not evaluated. A healthcare professional can help sort out which of those is actually driving low desire.
Frequently Asked Questions
How long does Vyleesi take to work?
Most people who respond notice an effect within 30 to 60 minutes of injecting, and it typically lasts about two to four hours. Vyleesi is dosed as needed, at least 45 minutes before sexual activity, with no more than one dose in 24 hours and no more than eight doses per month.
Is there an FDA-approved PT-141 nasal spray?
No. The only FDA-approved form of bremelanotide is the Vyleesi subcutaneous injection for premenopausal women with hypoactive sexual desire disorder. Nasal sprays sold online as PT-141 are compounded or research-grade products that have not been reviewed for purity, sterility, or dosing accuracy.
Can men use Vyleesi?
Vyleesi is not FDA-approved for men. Some men use compounded bremelanotide off-label and report effects similar to those seen in women, including nausea and flushing, but no large trial supports that use and there is no approved male product. Anyone considering it should talk with a healthcare professional first.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.